These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 10800753)
21. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine. Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197 [TBL] [Abstract][Full Text] [Related]
22. Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Burbaud P; Gross C; Benazzouz A; Coussemacq M; Bioulac B Exp Brain Res; 1995; 105(1):48-58. PubMed ID: 7589317 [TBL] [Abstract][Full Text] [Related]
23. Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset. Mackenzie GM; Jackson MJ; Jenner P; Marsden CD Synapse; 1997 Jul; 26(3):301-16. PubMed ID: 9183819 [TBL] [Abstract][Full Text] [Related]
24. Genome-wide analysis of DNA methylation during antagonism of DMOG to MnCl2-induced cytotoxicity in the mouse substantia nigra. Yang N; Wei Y; Wang T; Guo J; Sun Q; Hu Y; Yan X; Zhu X; Tang B; Xu Q Sci Rep; 2016 Jul; 6():28933. PubMed ID: 27380887 [TBL] [Abstract][Full Text] [Related]
25. Effect of neurotoxic lesion of pedunculopontine nucleus in nigral and striatal redox balance and motor performance in rats. Jimenez-Martin J; Blanco-Lezcano L; González-Fraguela ME; Díaz-Hung ML; Serrano-Sánchez T; Almenares JL; Francis-Turner L Neuroscience; 2015 Mar; 289():300-14. PubMed ID: 25596320 [TBL] [Abstract][Full Text] [Related]
26. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits. Zhang J; Stanton DM; Nguyen XV; Liu M; Zhang Z; Gash D; Bing G Neuroscience; 2005; 135(3):829-38. PubMed ID: 16165292 [TBL] [Abstract][Full Text] [Related]
27. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies. Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858 [TBL] [Abstract][Full Text] [Related]
28. Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice. Del Bel EA; Guimarães FS Psychopharmacology (Berl); 2000 Jan; 147(4):356-61. PubMed ID: 10672628 [TBL] [Abstract][Full Text] [Related]
29. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats. Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890 [TBL] [Abstract][Full Text] [Related]
30. Effects of both 6-hydroxydopamine-induced and electrolytic lesion of the substantia nigra on the rotational behavior and audiogenic seizures in the rat. Garcia-Cairasco N; Trivińo-Santos HF Braz J Med Biol Res; 1989; 22(5):617-29. PubMed ID: 2515906 [TBL] [Abstract][Full Text] [Related]
31. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease. Liu H; Jia L; Chen X; Shi L; Xie J Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294 [TBL] [Abstract][Full Text] [Related]
32. Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase. Gomes MZ; Del Bel EA Brain Res Bull; 2003 Dec; 62(2):107-15. PubMed ID: 14638384 [TBL] [Abstract][Full Text] [Related]
33. In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson's disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model. Soria G; Aguilar E; Tudela R; Mullol J; Planas AM; Marin C Eur J Neurosci; 2011 Apr; 33(8):1551-60. PubMed ID: 21410791 [TBL] [Abstract][Full Text] [Related]
34. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis. Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Cox RF; Waszczak BL Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308 [TBL] [Abstract][Full Text] [Related]
36. Effects of MnDPDP, DPDP--, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart. Brurok H; Schjøtt J; Berg K; Karlsson JO; Jynge P Invest Radiol; 1997 Apr; 32(4):205-11. PubMed ID: 9101355 [TBL] [Abstract][Full Text] [Related]
37. Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers. Sengstock GJ; Olanow CW; Menzies RA; Dunn AJ; Arendash GW J Neurosci Res; 1993 May; 35(1):67-82. PubMed ID: 7685399 [TBL] [Abstract][Full Text] [Related]
38. Neuroethological evaluation of audiogenic seizures and audiogenic-like seizures induced by microinjection of bicuculline into the inferior colliculus. II. Effects of nigral clobazam microinjections. Terra VC; Garcia-Cairasco N Behav Brain Res; 1992 Nov; 52(1):19-28. PubMed ID: 1335262 [TBL] [Abstract][Full Text] [Related]
39. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis. Connop BP; Boegman RJ; Jhamandas K; Beninger RJ Brain Res; 1995 Apr; 676(1):124-32. PubMed ID: 7540931 [TBL] [Abstract][Full Text] [Related]
40. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease. Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]